A phase I first-in-human study of TRC105 (Anti-Endoglin Antibody) in patients with advanced cancer.
Rosen LS, Hurwitz HI, Wong MK, Goldman J, Mendelson DS, Figg WD, Spencer S, Adams BJ, Alvarez D, Seon BK, Theuer CP, Leigh BR, Gordon MS.
Rosen LS, et al.
Clin Cancer Res. 2012 Sep 1;18(17):4820-9. doi: 10.1158/1078-0432.CCR-12-0098. Epub 2012 Jul 5.
Clin Cancer Res. 2012.
PMID: 22767667
Free PMC article.
Clinical Trial.